IGF2 and thyroid gland carcinoma: In undifferentiated thyroid cancer cells, DDR1 downregulation inhibits the IGF2/IR-A signaling pathway and increases the expression of differentiation markers, such as TSH and TPO, and decrease of EMT and stemness markers, like Nanog, ABCG2 and vimentin [145].